Preventing nerve function impairment in leprosy: Validation and updating of a prediction rule

PLoS Neglected Tropical Diseases

Volumn 2, Issue 8, 2008, Pages

  Schuring, Ron P ^a   Richardus, Jan H ^b   Steyerberg, Ewout W ^b   Pahan, David ^c   Faber, William R ^d   Oskam, Linda ^a  

^a ROYAL TROPICAL INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Danish Bangladesh Leprosy Mission   (Bangladesh)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CORTICOSTEROID; PHENOLIC GLYCOLIPID I ANTIBODY; UNCLASSIFIED DRUG; LEPROSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHILD; DISEASE SURVEILLANCE; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; LEPROSY; MAJOR CLINICAL STUDY; MALE; NERVE FUNCTION IMPAIRMENT; NEUROPATHY; PREDICTION; PROGNOSIS; RISK ASSESSMENT; VALIDITY; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 56149109161     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000283     Document Type: Article

References (18)

1. World Health Organization (1980) International classification of impairments, disabilities and handicaps. Geneva: World Health Organization.
2. Job CK (1989) Nerve damage in leprosy. Int Lepr other Mycobact Dis 57: 523-39.
3. Smith WCS, Anderson AM, Withington SG, van Brakel WH, Croft RP, et al. (2004) Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1). BMJ 328: 1459-62.
4. Croft RP, Nicholls PG, Steyerberg EW, Richardus JH, Smith WCS (2000) A clinical prediction rule for nerve-function-impairment in leprosy patients. Lancet 355: 1603-6.
5. Roche PW, Theuvenet WJ, Britton WJ (1991) Risk factors for type-1 reactions in borderline leprosy patients. Lancet 338: 654-7.
6. Kumar B, Dogra S, Kaur I (2004) Epidemiological characteristics of leprosy reactions: 15 years experience from north India. Int J Lepr Other Mycobact Dis 72: 125-33.
7. Van Veen NH, Meima A, Richardus JH (2006) The relationship between detection delay and impairment in leprosy control: a comparison of patient cohorts from Bangladesh and Ethiopia. Lepr Rev 77: 356-65.
8. Bührer-Sékula S, Visschedijk J, Grossi MAF, Dhakal KP, Namad AU, et al. (2007) The ML Flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients. Lepr Rev 78: 70-9.
9. Bührer-Sékula S, Smits HL, Gussenhoven GC, van Leeuwen J, Amador S, et al. (2000) Use of ML dipstick as a tool to classify leprosy patients. Int J Lepr Other Mycobact Dis 68: 456-63.
10. Moet FJ, Oskam L, Faber R, Pahan D, Richardus JH (2004) A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP. Lepr Rev 75: 376-88.
11. WHO Expert Committee on Leprosy (1998) Seventh Report WHO Technical Report Series. Geneva: World Health Organization 874.
12. Danish Bangladesh Leprosy Mission (2000) Guidelines for the field management of nerve function impairment and reactions in leprosy. DBLM protocol revised December, 2000.
13. Anderson A, Croft RP (1999) Reliability of Semmes Weinstein monofilament and ballpoint sensory testing, and voluntary muscle testing in Bangladesh. Lepr Rev 70: 305-13.
14. Aids to the investigation of peripheral nerve injuries (Memo no. 7, 2nd edition) (1962) London HMSO.
15. Pattyn SR (1983) Minimal requirements for the laboratory diagnosis of leprosy in field conditions. Acta Leprol 1: 33-40.
16. Schuring RP, Moet FJ, Pahan D, Richardus JH, Oskam L (2006) Association between anti-PGL-I IgM and clinical and demographic parameters in leprosy. Lepr Rev 77: 343-55.
17. Fujiwara T, Hunter SW, Cho SN, Aspinall GO, Brennan PJ (1984) Chemical synthesis and serology of disaccharides and trisaccharides of phenolic glycolipid antigens from the leprosy bacillus and preparation of a disaccharide protein conjugate for serodiagnosis of leprosy. Infect Immun 43: 245-52.
18. Harrell FE (2001) Regression modelling strategies. New York: Springer.